Targeted Oncology

About Targeted Oncology

Targeted Oncology sits in Other / Uncategorized, a segment Bracken sees as structurally important to the radiopharma value chain.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Imaging Wire · 2026-09-20
  Targeted Oncology closes Series C round to scale radiopharma manufacturing
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• STAT News · 2026-06-15
  Targeted Oncology publishes dosimetry data at SNMMI 2026
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• Nuclear Medicine Today · 2026-03-14
  Targeted Oncology files IND for next-generation PSMA-targeted agent
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• PR Newswire · 2026-08-13
  Targeted Oncology partners with academic center on Actinium-225 program
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Reuters Health · 2026-05-04
  Targeted Oncology expands cyclotron capacity to meet Lu-177 demand
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.